Immatics

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Immatics and other ETFs, options, and stocks.

About IMTX

Immatics NV is a clinical stage biopharmaceutical company, which engages in the research and development of T cell receptor-based immunotherapies for the treatment of cancer. Its pipeline include adoptive cell therapy and TCR Bispecifics.The company was founded on March 10, 2020 and is headquartered in Tuebingen, Germany.

CEO

Harpreet Singh-Jasuja

CEOHarpreet Singh-Jasuja

Employees

255

Employees255

Headquarters

Tuebingen, Baden Wuerttemberg

HeadquartersTuebingen, Baden Wuerttemberg

Founded

2000

Founded2000

Employees

255

Employees255

IMTX Key Statistics

Market cap

586.84M

Market cap586.84M

Price-Earnings ratio

18.73

Price-Earnings ratio18.73

Dividend yield

—

Dividend yield—

Average volume

273.68K

Average volume273.68K

High today

$9.10

High today$9.10

Low today

$8.76

Low today$8.76

Open price

$8.93

Open price$8.93

Volume

187.01K

Volume187.01K

52 Week high

$14.90

52 Week high$14.90

52 Week low

$5.75

52 Week low$5.75

IMTX Earnings

-$0.54

$0.27

$1.07

$1.88

Q4 FY20

Q1 FY21

Q2 FY21

Q3 FY21

Q4 FY21

Q1 FY22

Q2 FY22

Q3 FY22

Estimated

— per share

Estimated— per share

Actual

Expected Nov 15, Pre-Market

ActualExpected Nov 15, Pre-Market